MLSS

Milestone Scientific Inc.

Price Chart

Latest Quote

$0.31

+0.01 (+2.62%)

Current Price

Previous Close	$0.30
Open	$0.30
Day High	$0.31
Day Low	$0.29
Volume	147,109

Fetched: 2026-06-24T20:04:01

Stock Information

Shares Outstanding	88.45M
Total Debt	$985K
Cash Equivalents	$1.19M
Revenue	$8.90M
Net Income	$-4.57M
Sector	Healthcare
Industry	Medical Instruments & Supplies
Market Cap	$27.07M
EPS (TTM)	$-0.06
Exchange	ASE

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$26.05M
Sales	$8.90M
Income	$-4.57M
Book/sh	$0.03
Cash/sh	$0.01
Employees	15

Financial Ratios

Quick Ratio	0.36
Current Ratio	1.51
Debt/Eq	43.12

Returns & Margins

ROA	-33.19%
ROE	-135.38%
Gross Margin	71.03%
Operating Margin	-38.30%
Profit Margin	-51.30%

Ownership

Insider Ownership	20.90%
Institutional Ownership	5.11%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-8.74
P/S	3.04
P/B	10.93

Analyst Data

Recommendation	none
Target Price	$1.00

Technical Indicators

SMA20	$0.37
SMA50	$0.36
SMA200	$0.35
RSI	33.59
ATR	0.0378

Shares Float	70.69M
Short Float	0.70%
Short Ratio	1.10
Volatility	1.02
Rel Volume	0.71

Performance History

Week	-10.00%
Month	-19.47%
Quarter	+5.52%
6 Months	-4.37%
YTD	+5.52%
Year	-61.75%
3 Years	-71.67%
5 Years	-84.55%
10 Years	-88.45%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-24	$0.31	147,109
2026-06-23	$0.30	871,200
2026-06-22	$0.33	260,400
2026-06-18	$0.37	414,200
2026-06-17	$0.34	74,400
2026-06-16	$0.34	248,800
2026-06-15	$0.34	101,400
2026-06-12	$0.35	95,400
2026-06-11	$0.36	66,500
2026-06-10	$0.39	247,900
2026-06-09	$0.39	272,500
2026-06-08	$0.38	253,500
2026-06-05	$0.42	137,700
2026-06-04	$0.43	228,100
2026-06-03	$0.39	70,600
2026-06-02	$0.39	173,200
2026-06-01	$0.39	86,500
2026-05-29	$0.39	95,000
2026-05-28	$0.40	104,900
2026-05-27	$0.39	168,600
2026-05-26	$0.37	163,900

About Milestone Scientific Inc.

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

📰 Latest News

Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...

GuruFocus.com • 2026-05-14T23:03:20Z

Milestone Scientific Inc. Q1 2026 Earnings Call Summary

Moby • 2026-05-14T21:21:49Z

Milestone Scientific Inc (MLSS) Q4 2025 Earnings Call Highlights: Strategic Growth and ...

GuruFocus.com • 2026-04-01T19:01:42Z

Milestone Scientific Inc. Q4 2025 Earnings Call Summary

Moby • 2026-04-01T12:30:00Z

Milestone Scientific Inc (MLSS) Q3 2025 Earnings Call Highlights: Strategic Expense Reductions ...

GuruFocus.com • 2025-11-14T21:00:44Z

Milestone Scientific Inc (MLSS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Driven ...

GuruFocus.com • 2025-08-16T07:02:24Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$2,458,943	$2,097,945	$2,945,975	$3,824,471
Cost Of Revenue	$2,566,405	$2,195,340	$3,034,832	$3,905,092
Total Revenue	$8,973,982	$8,629,928	$9,827,444	$8,805,906
Operating Revenue	$8,973,982	$8,629,928	$9,827,444	$8,805,906
Expenses
Total Expenses	$14,670,599	$15,386,885	$16,933,918	$17,633,379
Net Non Operating Interest Income Expense	$-25,599	$60,265	$125,527	$54,607
Total Other Finance Cost	$25,599	$-60,265	$-125,527	$-54,607
Operating Expense	$12,104,194	$13,191,545	$13,899,086	$13,728,287
Other Income Expense	-	$1,983,095	-	-
Other Non Operating Income Expenses	-	$1,983,095	-	-
Interest Expense	-	-	-	-
Interest Expense Non Operating	-	-	-	-
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Net Interest Income	$-25,599	$60,265	$125,527	$54,607
Normalized Income	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Net Income From Continuing And Discontinued Operation	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Total Operating Income As Reported	$-5,696,617	$-6,756,957	$-7,106,474	$-8,827,473
Net Income Common Stockholders	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Net Income	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Net Income Including Noncontrolling Interests	$-5,722,216	$-4,713,597	$-6,980,947	$-8,772,866
Net Income Continuous Operations	$-5,722,216	$-4,713,597	$-6,980,947	$-8,772,866
Pretax Income	$-5,722,216	$-4,713,597	$-6,980,947	$-8,772,866
Operating Income	$-5,696,617	$-6,756,957	$-7,106,474	$-8,827,473
Depreciation Amortization Depletion Income Statement	$78,195	$37,448	$61,912	$63,755
Depreciation And Amortization In Income Statement	$78,195	$37,448	$61,912	$63,755
Gross Profit	$6,407,577	$6,434,588	$6,792,612	$4,900,814
Earnings From Equity Interest Net Of Tax	-	-	-	$0
Special Income Charges	-	-	-	$0
Per Share
Diluted EPS	$-0.07	$-0.06	$-0.10	$-0.12
Basic EPS	$-0.07	$-0.06	$-0.10	$-0.12
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-5,510,960	$-6,622,114	$-6,955,705	$-8,683,097
Reconciled Depreciation	$185,657	$134,843	$150,769	$144,376
EBITDA (Bullshit earnings)	$-5,510,960	$-6,622,114	$-6,955,705	$-8,683,097
EBIT	$-5,696,617	$-6,756,957	$-7,106,474	$-8,827,473
Diluted Average Shares	$82,064,109	$79,791,188	$72,775,781	$70,607,338
Basic Average Shares	$82,064,109	$79,791,188	$72,775,781	$70,607,338
Diluted NI Availto Com Stockholders	$-5,722,216	$-4,713,597	$-6,929,104	$-8,706,131
Minority Interests	$0	$0	$51,843	$66,735
Tax Provision	$0	$0	$0	$0
Research And Development	$449,469	$858,767	$701,378	$1,150,209
Selling General And Administration	$11,576,530	$12,295,330	$13,135,796	$12,514,323
Total Unusual Items	-	-	-	$0
Total Unusual Items Excluding Goodwill	-	-	-	$0
Other Special Charges	-	-	-	-

Fetched: 2026-06-22

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$2,733,560	$5,684,296	$7,833,876	$9,997,754
Total Assets	$7,806,429	$9,797,072	$11,371,512	$13,702,086
Total Non Current Assets	$328,594	$510,518	$577,043	$731,582
Other Non Current Assets	$24,150	$24,150	$24,150	$24,150
Goodwill And Other Intangible Assets	$79,063	$148,404	$178,636	$227,956
Other Intangible Assets	$79,063	$148,404	$178,636	$227,956
Current Assets	$7,477,834	$9,286,554	$10,794,469	$12,970,504
Other Current Assets	$468,792	$564,645	$517,785	$443,872
Prepaid Assets	$1,408,395	$1,275,260	$1,371,548	$1,325,301
Inventory	$3,781,837	$3,713,215	$2,638,186	$1,792,335
Receivables	$706,168	$475,376	$312,664	$693,717
Accounts Receivable	$680,620	$475,376	$312,664	$693,717
Allowance For Doubtful Accounts Receivable	$-10,000	$-10,000	$-10,000	$-10,000
Gross Accounts Receivable	$690,620	$485,376	$322,664	$703,717
Cash Cash Equivalents And Short Term Investments	$1,112,642	$3,258,058	$5,954,286	$8,715,279
Cash And Cash Equivalents	$1,112,642	$3,258,058	$2,977,713	$8,715,279
Debt
Total Debt	$1,020,246	$349,054	$395,978	$497,043
Long Term Debt And Capital Lease Obligation	$862,544	$220,245	$282,287	$395,977
Long Term Debt	$800,000	-	-	-
Current Debt And Capital Lease Obligation	$157,702	$128,809	$113,691	$101,066
Liabilities
Total Liabilities Net Minority Interest	$4,993,806	$3,964,372	$3,359,000	$3,695,652
Total Non Current Liabilities Net Minority Interest	$862,544	$220,245	$282,287	$395,977
Current Liabilities	$4,131,262	$3,744,127	$3,076,713	$3,299,675
Payables And Accrued Expenses	$3,973,560	$3,615,318	$2,963,022	$3,198,609
Payables	$2,789,948	$1,514,706	$1,100,116	$1,906,221
Accounts Payable	$1,430,250	$1,021,393	$689,604	$1,102,729
Current Deferred Liabilities	-	-	-	-
Current Notes Payable	-	-	-	-
Equity
Common Stock Equity	$2,812,623	$5,832,700	$8,012,512	$10,225,710
Total Equity Gross Minority Interest	$2,812,623	$5,832,700	$8,012,512	$10,006,434
Stockholders Equity	$2,812,623	$5,832,700	$8,012,512	$10,225,710
Retained Earnings	$-133,775,322	$-128,053,106	$-123,339,509	$-116,410,405
Other
Treasury Shares Number	$33,333	$33,333	$33,333	$33,333
Ordinary Shares Number	$80,453,116	$78,014,465	$75,848,507	$69,273,164
Share Issued	$80,486,449	$78,047,798	$75,881,840	$69,306,497
Tangible Book Value	$2,733,560	$5,684,296	$7,833,876	$9,997,754
Invested Capital	$3,612,623	$5,832,700	$8,012,512	$10,225,710
Working Capital	$3,346,572	$5,542,427	$7,717,756	$9,670,829
Capital Lease Obligations	$220,246	$349,054	$395,978	$497,043
Total Capitalization	$3,612,623	$5,832,700	$8,012,512	$10,225,710
Treasury Stock	$911,516	$911,516	$911,516	$911,516
Additional Paid In Capital	$137,418,974	$134,719,274	$132,187,656	$127,478,325
Capital Stock	$80,487	$78,048	$75,881	$69,306
Common Stock	$80,487	$78,048	$75,881	$69,306
Long Term Capital Lease Obligation	$62,544	$220,245	$282,287	$395,977
Current Capital Lease Obligation	$157,702	$128,809	$113,691	$101,066
Current Accrued Expenses	$1,183,612	$2,100,612	$1,862,906	$1,292,388
Dueto Related Parties Current	$1,359,698	$493,313	$410,512	$803,492
Net PPE	$225,381	$337,964	$374,257	$479,476
Accumulated Depreciation	$-932,970	$-925,830	$-918,610	$-905,611
Gross PPE	$1,158,351	$1,263,794	$1,292,867	$1,385,087
Leases	$24,734	$24,734	$24,734	$24,734
Other Properties	$495,626	$614,480	$653,670	$750,767
Machinery Furniture Equipment	$637,991	$624,580	$614,463	$609,586
Properties	$0	$0	$0	$0
Finished Goods	$3,707,245	$3,640,391	$2,419,700	$1,649,387
Raw Materials	$74,592	$72,824	$218,486	$142,948
Duefrom Related Parties Current	$25,548	-	-	-
Other Short Term Investments	-	$0	$2,976,573	$0
Minority Interest	-	-	$0	$-219,276
Current Deferred Revenue	-	-	-	-

Fetched: 2026-06-22

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-2,931,751	$-2,929,999	$-5,331,010	$-6,040,523
Operating Activities
Operating Cash Flow	$-2,916,627	$-2,919,875	$-5,326,129	$-6,031,996
Cash Flow From Continuing Operating Activities	$-2,916,627	$-2,919,875	$-5,326,129	$-6,031,996
Operating Gains Losses	-	-	-	-
Investing Activities
Capital Expenditure	$-15,124	$-10,124	$-4,881	$-8,527
Investing Cash Flow	$-15,124	$2,966,449	$-2,972,172	$-8,527
Cash Flow From Continuing Investing Activities	$-15,124	$2,966,449	$-2,972,172	$-8,527
Financing Activities
Issuance Of Capital Stock	$0	$192,156	$2,570,101	$0
Financing Cash Flow	$786,335	$233,771	$2,560,735	$-8,544
Cash Flow From Continuing Financing Activities	$786,335	$233,771	$2,560,735	$-8,544
Net Common Stock Issuance	$0	$192,156	$2,570,101	$0
Common Stock Issuance	$0	$192,156	$2,570,101	$0
Other
Repayment Of Debt	$-13,665	$-10,136	$-9,366	$-8,544
Issuance Of Debt	$800,000	$0	-	-
End Cash Position	$1,112,642	$3,258,058	$2,977,713	$8,715,279
Beginning Cash Position	$3,258,058	$2,977,713	$8,715,279	$14,764,346
Changes In Cash	$-2,145,416	$280,345	$-5,737,566	$-6,049,067
Proceeds From Stock Option Exercised	$0	$51,751	$0	$0
Net Issuance Payments Of Debt	$786,335	$-10,136	$-9,366	$-8,544
Net Long Term Debt Issuance	$786,335	$-10,136	$-9,366	$-8,544
Long Term Debt Payments	$-13,665	$-10,136	$-9,366	$-8,544
Long Term Debt Issuance	$800,000	$0	-	-
Net Investment Purchase And Sale	$0	$2,976,573	$-2,967,291	$0
Sale Of Investment	$0	$2,976,573	$4,966,213	$0
Net PPE Purchase And Sale	$-15,124	$-10,124	$-4,881	$-8,527
Purchase Of PPE	$-15,124	$-10,124	$-4,881	$-8,527
Change In Working Capital	$-93,846	$-631,000	$-1,400,470	$-549,723
Change In Other Current Assets	$-103,751	$-94,991	$-83,054	$-72,353
Change In Payables And Accrued Expense	$358,239	$652,304	$-449,585	$190,749
Change In Accrued Expense	$-917,003	$237,714	$356,521	$-539,187
Change In Payable	$1,275,242	$414,590	$-806,106	$729,936
Change In Account Payable	$1,275,242	$414,590	$-806,106	$729,936
Change In Prepaid Assets	$-37,281	$49,428	$-120,158	$-84,553
Change In Inventory	$-68,622	$-1,075,029	$-1,103,861	$-833,121
Change In Receivables	$-242,431	$-162,712	$356,188	$249,555
Changes In Account Receivables	$-242,431	$-162,712	$356,188	$249,555
Other Non Cash Items	$1,020,673	$579,801	$745,999	$747,351
Stock Based Compensation	$1,681,466	$1,710,078	$1,884,926	$1,816,567
Asset Impairment Charge	$11,639	$0	$24,865	$0
Depreciation Amortization Depletion	$185,657	$134,843	$150,769	$144,376
Depreciation And Amortization	$185,657	$134,843	$150,769	$144,376
Amortization Cash Flow	$69,341	$30,232	$49,320	$49,663
Amortization Of Intangibles	$69,341	$30,232	$49,320	$49,663
Depreciation	$116,316	$104,611	$101,449	$94,713
Net Income From Continuing Operations	$-5,722,216	$-4,713,597	$-6,980,947	$-8,772,866
Purchase Of Investment	-	$0	$-7,933,504	$0
Unrealized Gain Loss On Investment Securities	-	$0	$-9,282	$0
Provisionand Write Offof Assets	-	$0	$258,011	$582,299
Change In Other Current Liabilities	-	-	-	$-72,353
Earnings Losses From Equity Investments	-	-	-	$0

Fetched: 2026-06-22